Search Results for keywords:"Federal eRulemaking Portal"

The U.S. Department of Health and Human Services (HHS) Office of Minority Health is seeking feedback from Native Hawaiian and Pacific Islander (NHPI) communities and organizations to help develop a new Center for Indigenous Innovation and Health Equity. This center aims to improve health outcomes by focusing on indigenous public health strategies for American Indian, Alaska Native, Native Hawaiian, and Pacific Islander populations. Feedback is requested by March 14, 2021, through the Federal eRulemaking Portal or via email. This is a request for information and does not involve a call for funding proposals or involve financial commitments from the government.

LTS Therapy Systems, LLC is seeking to become a registered importer of certain controlled substances for research and development purposes. The Drug Enforcement Administration (DEA) is asking for public comments or objections to this application by April 7, 2025. Comments must be submitted electronically through the Federal eRulemaking Portal. The company is not permitted to import these substances for commercial sale, and any registration approval will align with legal requirements.

The Department of Homeland Security (DHS), through U.S. Citizenship and Immigration Services (USCIS), is inviting public comments on a proposed extension of an existing information collection regarding the Application for Provisional Unlawful Presence Waiver of Inadmissibility (Form I-601A). This notice allows an additional 30 days for comments concerning the necessity and efficiency of this information collection, which aids USCIS in determining an applicant’s eligibility for the waiver. Public feedback is requested on matters such as the collection's estimated burden and any potential improvements, and comments must be submitted by March 29, 2021, via the Federal eRulemaking Portal. The submission of Form I-601A is crucial for individuals seeking to qualify for the provisional waiver process concerning unlawful presence inadmissibility, affecting about 63,000 respondents with a total estimated annual public burden of 168,210 hours and a cost burden of $3,212,390.

The Office of the Under Secretary of Defense for Personnel and Readiness is seeking public comments on a proposed information collection in compliance with the Paperwork Reduction Act. This effort involves collecting data through DD Form 369, a Police Record Check, to assess the eligibility of individuals for military service based on their criminal history. The process aims to ensure that candidates meet minimal standards under U.S. Code Sections 504, 505, and 12102, which prohibit the enlistment of felons and others with certain types of criminal records. Feedback is requested by February 28, 2025, to enhance the information collection process and minimize the burden on respondents.

The Drug Enforcement Administration (DEA) has announced that Sterling Wisconsin, LLC applied to register as a bulk manufacturer of certain controlled substances, specifically synthetic versions of Marihuana Extract, Marihuana, and Tetrahydrocannabinols. Interested parties can submit comments or objections electronically or request a hearing until May 27, 2025. The application was filed on January 30, 2025, and comments should be submitted via the Federal eRulemaking Portal as instructed.

Organic Consultants LLC, doing business as Cascade Chemistry, has applied to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of certain controlled substances. Interested parties have until April 1, 2025, to submit comments or objections regarding the application or to request a hearing. Comments can be submitted electronically through the Federal eRulemaking Portal. The company intends to produce small amounts of these substances for internal use or to sell as analytical reference standard materials, with no other activities authorized for these drug codes.

The Stepan Company has applied to the Drug Enforcement Administration (DEA) to be registered as an importer of certain controlled substances, as per the notice from the Justice Department's DEA. The application is to import these substances to manufacture other controlled substances, but not for commercial sale in finished form. Interested parties, such as current manufacturers or applicants, can comment or request a hearing about this application until April 9, 2025. Comments and hearing requests should be submitted through specified DEA addresses or electronically via the Federal eRulemaking Portal.

Invizyne Technologies, Inc. has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of certain controlled substances, including synthetic Tetrahydrocannabinols. Stakeholders, such as current manufacturers and applicants, can submit comments or objections electronically through the Federal eRulemaking Portal by March 24, 2025, and may also request a hearing by the same date. The DEA has provided detailed instructions for submitting comments online and has assured that comments will receive a Comment Tracking Number upon successful submission.

Sterling Pharma USA LLC has applied to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of controlled substances. This application, filed on February 11, 2025, aims to support the company's internal research and provide substances for pre-clinical trial studies. The public can comment or object to this registration until May 16, 2025, through the Federal eRulemaking Portal.

Veranova, L.P. has applied to become a registered bulk manufacturer of specific controlled substances. The application has been submitted to the Drug Enforcement Administration (DEA) to support their manufacturing and analytical testing needs. Public comments or objections regarding this application can be submitted electronically through the Federal eRulemaking Portal until March 25, 2025. Individuals may also request a hearing about the application by the same date.